Barrett JR, Belij-Rammerstorfer S, Dold C, Ewer KJ, et al. Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses. Nat Med 2020 Dec 17. pii: 10.1038/s41591-020-01179.
PMID: 33335322